This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Interleukin-6: an emerging regulator of pathological pain
Journal of Neuroinflammation Open Access 07 June 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Datamonitor. Epidemiology: Peripheral Neuropathic pain — A common co-morbidity for HIV, diabetes, and herpes zoster. HC00221–001 (October 2011)
Datamonitor. R&D Trends: Neuropathic pain — Extensive and diverse pipeline driven by high unmet need. HC00064–006 (July 2011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Nightingale, S. The neuropathic pain market. Nat Rev Drug Discov 11, 101–102 (2012). https://doi.org/10.1038/nrd3624
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3624
This article is cited by
-
Long Noncoding RNA SNHG5 Knockdown Alleviates Neuropathic Pain by Targeting the miR-154-5p/CXCL13 Axis
Neurochemical Research (2020)
-
Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic glutamate receptor 4
Molecular Psychiatry (2018)
-
New consensus multivariate models based on PLS and ANN studies of sigma-1 receptor antagonists
Journal of Molecular Modeling (2017)
-
Interleukin-6: an emerging regulator of pathological pain
Journal of Neuroinflammation (2016)
-
A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
Neuropsychopharmacology (2015)